{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T01:05:13Z","timestamp":1778807113507,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL071558 HL109397 HL132953, HL107885"],"award-info":[{"award-number":["HL071558 HL109397 HL132953, HL107885"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s12012-020-09605-2","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T12:02:56Z","timestamp":1599134576000},"page":"142-151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Thioredoxin Decreases Anthracycline Cardiotoxicity, But Sensitizes Cancer Cell Apoptosis"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7734-3368","authenticated-orcid":false,"given":"Kumuda C.","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harish","family":"Muniyappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkatesh","family":"Kundumani-Sridharan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaganathan","family":"Subramani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"9605_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fcvm.2020.00026","volume":"7","author":"D Cardinale","year":"2020","unstructured":"Cardinale, D., Iacopo, F., & Cipolla, C. M. (2020). Cardiotoxicity of anthracyclines. Frontiers in Cardiovascular Medicine, 7, 26.","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"9605_CR2","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/sj.bjc.6603562","volume":"96","author":"J Bryant","year":"2007","unstructured":"Bryant, J., Picot, J., Baxter, L., Levitt, G., Sullivan, I., & Clegg, A. (2007). Clinical and cost-effectiveness of cardioprotection against the toxic effects of anthracyclines given to children with cancer: A systematic review. British Journal of Cancer, 96, 226\u2013230.","journal-title":"British Journal of Cancer"},{"key":"9605_CR3","doi-asserted-by":"publisher","first-page":"172818","DOI":"10.1016\/j.ejphar.2019.172818","volume":"866","author":"N Prathumsap","year":"2020","unstructured":"Prathumsap, N., Shinlapawittayatorn, K., Chattipakorn, S. C., & Chattipakorn, N. (2020). Effects of doxorubicin on the heart: From molecular mechanisms to intervention strategies. European Journal of Pharmacology, 866, 172818.","journal-title":"European Journal of Pharmacology"},{"key":"9605_CR4","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1200\/JCO.1987.5.3.354","volume":"5","author":"GN Hortobagyi","year":"1987","unstructured":"Hortobagyi, G. N., Bodey, G. P., Buzdar, A. U., Frye, D., Legha, S. S., Malik, R., et al. (1987). Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: A prospective randomized study. Journal of Clinical Oncology, 5, 354\u2013364.","journal-title":"Journal of Clinical Oncology"},{"key":"9605_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1200\/JCO.1996.14.1.35","volume":"14","author":"RC Coombes","year":"1996","unstructured":"Coombes, R. C., Bliss, J. M., Wils, J., Morvan, F., Espie, M., Amadori, D., et al. (1996). Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: results of a randomized trial. The International Collaborative Cancer Group. Journal of Clinical Oncology, 14, 35\u201345.","journal-title":"Journal of Clinical Oncology"},{"key":"9605_CR6","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1056\/NEJM199302253280808","volume":"328","author":"VT DeVita Jr","year":"1993","unstructured":"DeVita, V. T., Jr., & Hubbard, S. M. (1993). Hodgkin's disease. New England Journal of Medicine, 328, 560\u2013565.","journal-title":"New England Journal of Medicine"},{"key":"9605_CR7","first-page":"11","volume":"5","author":"TM Long","year":"2019","unstructured":"Long, T. M., Marsh, C. E., Dembo, L. G., Watson, P., Wallman, K. E., Walwyn, T. S., et al. (2019). Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy. Cardiooncology, 5, 11.","journal-title":"Cardiooncology"},{"key":"9605_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ahj.2020.05.008","volume":"226","author":"WJ Bottinor","year":"2020","unstructured":"Bottinor, W. J., Soslow, J. H., Godown, J., Stoddard, M. F., Osmundson, E. C., Lenneman, C. G., et al. (2020). Childhood cancer survivors: The integral role of the cardiologist and cardiovascular imaging. American Heart Journal, 226, 127\u2013139.","journal-title":"American Heart Journal"},{"key":"9605_CR9","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1053\/j.seminoncol.2006.04.020","volume":"33","author":"P Elliott","year":"2006","unstructured":"Elliott, P. (2006). Pathogenesis of cardiotoxicity induced by anthracyclines. Seminars in Oncology, 33, S2\u20137.","journal-title":"Seminars in Oncology"},{"key":"9605_CR10","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1056\/NEJM199809243391307","volume":"339","author":"PK Singal","year":"1998","unstructured":"Singal, P. K., & Iliskovic, N. (1998). Doxorubicin-induced cardiomyopathy. New England Journal of Medicine, 339, 900\u2013905.","journal-title":"New England Journal of Medicine"},{"key":"9605_CR11","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ejca.2005.11.003","volume":"42","author":"HL Curry","year":"2006","unstructured":"Curry, H. L., Parkes, S. E., Powell, J. E., & Mann, J. R. (2006). Caring for survivors of childhood cancers: the size of the problem. European Journal of Cancer, 42, 501\u2013508.","journal-title":"European Journal of Cancer"},{"key":"9605_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev.bi.54.070185.001321","volume":"54","author":"A Holmgren","year":"1985","unstructured":"Holmgren, A. (1985). Thioredoxin. Annual Review of Biochemistry, 54, 237\u2013271.","journal-title":"Annual Review of Biochemistry"},{"key":"9605_CR13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0076-6879(95)52023-6","volume":"252","author":"A Holmgren","year":"1995","unstructured":"Holmgren, A., & Bjornstedt, M. (1995). Thioredoxin and thioredoxin reductase. Methods in Enzymology, 252, 199\u2013208.","journal-title":"Methods in Enzymology"},{"key":"9605_CR14","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/S0006-291X(05)81536-0","volume":"186","author":"A Mitsui","year":"1992","unstructured":"Mitsui, A., Hirakawa, T., & Yodoi, J. (1992). Reactive oxygen-reducing and protein-refolding activities of adult T cell leukemia-derived factor\/human thioredoxin. Biochemical and Biophysical Research Communications, 186, 1220\u20131226.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"9605_CR15","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1006\/bbrc.2000.3689","volume":"277","author":"KC Das","year":"2000","unstructured":"Das, K. C., & Das, C. K. (2000). Thioredoxin, a singlet oxygen quencher and hydroxyl radical scavenger: redox independent functions. Biochemical and Biophysical Research Communications, 277, 443\u2013447.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"9605_CR16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev.biophys.30.1.421","volume":"30","author":"G Powis","year":"2001","unstructured":"Powis, G., & Montfort, W. R. (2001). Properties and biological activities of thioredoxins. Annual Review of Biophysics and Biomolecular Structure, 30, 421\u2013455.","journal-title":"Annual Review of Biophysics and Biomolecular Structure"},{"key":"9605_CR17","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1165\/ajrcmb.17.6.2809","volume":"17","author":"KC Das","year":"1997","unstructured":"Das, K. C., Lewis-Molock, Y., & White, C. W. (1997). Elevation of manganese superoxide dismutase gene expression by thioredoxin. American Journal of Respiratory Cell and Molecular Biology, 17, 713\u2013726.","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"9605_CR18","doi-asserted-by":"publisher","first-page":"24161","DOI":"10.1016\/S0021-9258(18)35742-9","volume":"267","author":"A Rubartelli","year":"1992","unstructured":"Rubartelli, A., Bajetto, A., Allavena, G., Wollman, E., & Sitia, R. (1992). Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. Journal of Biological Chemistry, 267, 24161\u201324164.","journal-title":"Journal of Biological Chemistry"},{"key":"9605_CR19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00280-004-0833-y","volume":"54","author":"D Ravi","year":"2004","unstructured":"Ravi, D., & Das, K. C. (2004). Redox-cycling of anthracyclines by thioredoxin system: increased superoxide generation and DNA damage. Cancer Chemotherapy and Pharmacology, 54, 449\u2013458.","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"9605_CR20","doi-asserted-by":"publisher","first-page":"40084","DOI":"10.1074\/jbc.M507192200","volume":"280","author":"D Ravi","year":"2005","unstructured":"Ravi, D., Muniyappa, H., & Das, K. C. (2005). Endogenous thioredoxin is required for redox cycling of anthracyclines and p53-dependent apoptosis in cancer cells. Journal of Biological Chemistry, 280, 40084\u201340096.","journal-title":"Journal of Biological Chemistry"},{"key":"9605_CR21","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1021\/tx300069r","volume":"25","author":"Y Shinkai","year":"2012","unstructured":"Shinkai, Y., Iwamoto, N., Miura, T., Ishii, T., Cho, A. K., & Kumagai, Y. (2012). Redox cycling of 1,2-naphthoquinone by thioredoxin1 through Cys32 and Cys35 causes inhibition of its catalytic activity and activation of ASK1\/p38 signaling. Chemical Research in Toxicology, 25, 1222\u20131230.","journal-title":"Chemical Research in Toxicology"},{"key":"9605_CR22","doi-asserted-by":"publisher","first-page":"4662","DOI":"10.1074\/jbc.M006206200","volume":"276","author":"KC Das","year":"2001","unstructured":"Das, K. C. (2001). c-Jun NH2-terminal kinase-mediated redox-dependent degradation of IkappaB: Role of thioredoxin in NF-kappaB activation. Journal of Biological Chemistry, 276, 4662\u20134670.","journal-title":"Journal of Biological Chemistry"},{"key":"9605_CR23","doi-asserted-by":"publisher","first-page":"17069","DOI":"10.1074\/jbc.M109.008557","volume":"284","author":"H Muniyappa","year":"2009","unstructured":"Muniyappa, H., Song, S., Mathews, C. K., & Das, K. C. (2009). Reactive oxygen species-independent oxidation of thioredoxin in hypoxia: Inactivation of ribonucleotide reductase and redox-mediated checkpoint control. Journal of Biological Chemistry, 284, 17069\u201317081.","journal-title":"Journal of Biological Chemistry"},{"key":"9605_CR24","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.coph.2006.02.004","volume":"6","author":"ER Plummer","year":"2006","unstructured":"Plummer, E. R. (2006). Inhibition of poly(ADP-ribose) polymerase in cancer. Current Opinion in Pharmacology, 6, 364\u2013368.","journal-title":"Current Opinion in Pharmacology"},{"key":"9605_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1023\/A:1016119328968","volume":"7","author":"C Soldani","year":"2002","unstructured":"Soldani, C., & Scovassi, A. I. (2002). Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: An update. Apoptosis, 7, 321\u2013328.","journal-title":"Apoptosis"},{"key":"9605_CR26","first-page":"10","volume":"25","author":"C Myers","year":"1998","unstructured":"Myers, C. (1998). The role of iron in doxorubicin-induced cardiomyopathy. Seminars in Oncology, 25, 10\u201314.","journal-title":"Seminars in Oncology"},{"key":"9605_CR27","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1365-2141.2004.04803.x","volume":"124","author":"GA Levitt","year":"2004","unstructured":"Levitt, G. A., Dorup, I., Sorensen, K., & Sullivan, I. (2004). Does anthracycline administration by infusion in children affect late cardiotoxicity? British Journal of Haematology, 124, 463\u2013468.","journal-title":"British Journal of Haematology"},{"key":"9605_CR28","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1200\/JCO.2001.19.5.1444","volume":"19","author":"G Batist","year":"2001","unstructured":"Batist, G., Ramakrishnan, G., Rao, C. S., Chandrasekharan, A., Gutheil, J., Guthrie, T., et al. (2001). Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer. Journal of Clinical Oncology, 19, 1444\u20131454.","journal-title":"Journal of Clinical Oncology"},{"key":"9605_CR29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/BF01358885","volume":"4","author":"K Hellmann","year":"1996","unstructured":"Hellmann, K. (1996). Cardioprotection by dexrazoxane (Cardioxane; ICRF 187): progress in supportive care. Supportive Care in Cancer, 4, 305\u2013307.","journal-title":"Supportive Care in Cancer"},{"key":"9605_CR30","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1161\/01.CIR.0000027817.55925.B4","volume":"106","author":"K Shioji","year":"2002","unstructured":"Shioji, K., Kishimoto, C., Nakamura, H., Masutani, H., Yuan, Z., Oka, S., et al. (2002). Overexpression of thioredoxin-1 in transgenic mice attenuates adriamycin-induced cardiotoxicity. Circulation, 106, 1403\u20131409.","journal-title":"Circulation"},{"key":"9605_CR31","first-page":"4293","volume":"55","author":"A Yokomizo","year":"1995","unstructured":"Yokomizo, A., Ono, M., Nanri, H., Makino, Y., Ohga, T., Wada, M., et al. (1995). Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Cancer Research, 55, 4293\u20134296.","journal-title":"Cancer Research"},{"key":"9605_CR32","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1182\/blood.V89.7.2480","volume":"89","author":"J Wang","year":"1997","unstructured":"Wang, J., Kobayashi, M., Sakurada, K., Imamura, M., Moriuchi, T., & Hosokawa, M. (1997). Possible roles of an adult T-cell leukemia (ATL)-derived factor\/thioredoxin in the drug resistance of ATL to adriamycin. Blood, 89, 2480\u20132487.","journal-title":"Blood"},{"key":"9605_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1006\/abbi.2001.2435","volume":"392","author":"MI Berggren","year":"2001","unstructured":"Berggren, M. I., Husbeck, B., Samulitis, B., Baker, A. F., Gallegos, A., & Powis, G. (2001). Thioredoxin peroxidase-1 (peroxiredoxin-1) is increased in thioredoxin- 1 transfected cells and results in enhanced protection against apoptosis caused by hydrogen peroxide but not by other agents including dexamethasone, etoposide, and doxorubicin. Archives of Biochemistry and Biophysics, 392, 103\u2013109.","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"9605_CR34","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1038\/sj.onc.1204477","volume":"20","author":"X Ma","year":"2001","unstructured":"Ma, X., Karra, S., Lindner, D. J., Hu, J., Reddy, S. P., Kimchi, A., et al. (2001). Thioredoxin participates in a cell death pathway induced by interferon and retinoid combination. Oncogene, 20, 3703\u20133715.","journal-title":"Oncogene"},{"key":"9605_CR35","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.4049\/jimmunol.161.12.6689","volume":"161","author":"S Ueda","year":"1998","unstructured":"Ueda, S., Nakamura, H., Masutani, H., Sasada, T., Yonehara, S., Takabayashi, A., et al. (1998). Redox regulation of caspase-3(-like) protease activity: regulatory roles of thioredoxin and cytochrome c. The Journal of Immunology, 161, 6689\u20136695.","journal-title":"The Journal of Immunology"},{"key":"9605_CR36","doi-asserted-by":"publisher","first-page":"17505","DOI":"10.1074\/jbc.M115.660365","volume":"290","author":"V Kundumani-Sridharan","year":"2015","unstructured":"Kundumani-Sridharan, V., Subramani, J., & Das, K. C. (2015). Thioredoxin activates MKK4-NFkappaB pathway in a redox dependent manner to control manganese superoxide dismutase gene expression in endothelial cells. Journal of Biological Chemistry, 290, 17505\u201317509. https:\/\/doi.org\/10.1074\/jbc.M115.660365.","journal-title":"Journal of Biological Chemistry"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-020-09605-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-020-09605-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-020-09605-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T20:28:48Z","timestamp":1696624128000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-020-09605-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["9605"],"URL":"https:\/\/doi.org\/10.1007\/s12012-020-09605-2","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]},"assertion":[{"value":"29 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}